Hamza - Data Analyst SAS

Ref : 181213R001
Photo de Hamza, Data Analyst SAS
Compétences
Expériences professionnelles
  • Python : des fondamentaux aux concepts avancés du langage(France numérique)
    Jan 2018 - aujourd'hui

  • ;SAS® Programming for R Users
    Jan 2018 - aujourd'hui

  • Clinical Data Manager at Keyrus Biopharma (For Servier)
    Jan 2018 - aujourd'hui

    RESPONSIBILITIES
    Ensuing data management activities coordination (Phase I/PKH)
    Maaging subcontracted activities related to Paper CRF and eCRF studies
    Specification Writing/review of technical documents (DVP, DRF, IA, Transfer Protocol, ...)
    Performing quality control and validating database design
    Managing ueries
    Identifying and
    recording non conformities
    ACHIEVEMENTS
    Phase 1 (PKH/CL1):
    Conduct step of the study
    S95010-Safety, tolerability
    and pharmacokinetics after single escalating intravenous doses in young healthy male subjects. A randomised, double
    -blind, placebo-controlled, monocentre, First-In-Human study.

  • SAS programmer at MCT CRO

    ICON-DOCS Global(For Novartis).
    Jan 2017 - Jan 2018

    RESPONSIBILITIES
    Performng data manipulation, analysis and reporting of clinical trial data, both safety and efficacy;
    Creating analysis files, tables, listings, and figures (TLFs), validating those files, maintaining
    associated tracking and validation documentation;
    Writing Medium to high complexity SAS programs and macros.
    Deliver individual programming deliverables of
    medium to high complexity within a single project.
    Perform quality control in support of clinical trial activities.
    ACHIEVEMENTS
    Phase 3: Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor
    –Positive, Human
    Epidermal Growth Factor Receptor 2–
    Negative Advanced Breast Cancer
    Phase 2: Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001
    Administered to Patients With Advanced Malignancies
    Phase 1: Study of Subcutaneous Recombinant Human NIZ985 ((hetIL-15) (IL15/sIL-15Ra)) Alone
    and in Combination With PDR001 in Adults With Metastatic Cancers
    Phase 3 (pooled): 24-month Double
    -blind, Randomized, Multicenter, Placebo
    -controlled, Parallel
    -group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingo
    limod (FTY720)
    Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple
    Sclerosis With Optional Extension Phase

  • SAS programmer at DatametrixCRO

    Jan 2015 - Jan 2017

    RESPONSIBILITIES
    Programming of the deliverables, i.e. datasets and TLFs (Tables, Listings and Figures).
    Respecting all SOPs and BGs related to the tasks.
    Ensure that updated templates are respected and all available information is accounted for Projects.
    ACHIEVEMENTS
    Phase 3:
    A Multicenter, Open Label Study to Assess the Safety and Efficacy of 600 μg SOM230,
    Administered Subcutaneously, b.i.d. in Patients With Cushing's Disease
    -Novartis
    Phase 3: Multicenter Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild
    -type (wt), Advanced Non
    -small Cell Lung Cancer (NSCLC)-Novartis

    Phase 4: A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group
    Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypert
    ension-Actelion

    Phase 4: A Prospective, Multicenter, Single
    -arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by
    Cardiac Magnetic Resonance Imaging

    Efficacy and Tolerance Evaluation of an Anti -age Food Supplement: a Randomized, Controlled Clinical Study Versus Untreated Group–L’Oreal

  • Biostatistician at Poseidon Pharma CRO Services.
    Jan 2014 - Jan 2015

    RESPONSIBILITIES

    Sample size determination

    Assist in the implementation of protocol methodology and statistical analysis plans.

    Analyze clinical trial and healthcare marketing data producing accurate results representing the
    outcome of the trial or study, validate statistical output, accurately interpret and clearly communicate statistical results and concepts to non-statisticians.

    Contribute to the design and direction of research projects.

    ACHIEVEMENTS
    Phase 3: A Randomized, Placebo Controlled, Multicenter Clinical Study Investigating Efficacy of
    Rituximab in the Inhibition of Joint Structural Damage Assessed by Magnetic Reson
    ance Imaging in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate -Roche

    Epidemio-marketing study of the management of breast cancer patients in Tunisia -Roche

    Phase 4: Multicenter, Prospective, Placebo-Controlled Study toAssess Efficacy of Meteoxane in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) in Patients Who Report Inadequate Control of IBS-D Symptoms –Alpha Wassermnn

    Coordination and management of donation programs for patients with MULTI
    PLE SCLEROSIS -Merck October
    -December 2013: Census Supervisor at the National Institute of Statistics. Interships

  • Census Supervisor at the National Institute of Statistics. Interships
    Jan 2013 - aujourd'hui

  • Graduation Project at the Pasteur Institute in Tunis: "Survival Analysis and healing factoring of zoonotic cutaneous infection leshminiasis in Center of Tunisia"
    Jan 2013 - aujourd'hui

    engineering internship at the National Institute of Statistics: "Corrections of
    seasonal variations (CVS) by the method x11-x12 ARIMA."Graduation Project at the Pasteur Institute in Tunis: "Survival Analysis and
    healing factoring of zoonotic cutaneous infection leshminiasis in Center of Tunisia"

  • Jan 2012 - aujourd'hui

    engineering internship at the National Institute of Statistics: "Corrections of
    seasonal variations (CVS) by the method x11-x12 ARIMA."

  • 2011 - aujourd'hui

    Introductory internship in professional
    life at the Public Health Ministry, "Effect of the revolution on the behavior of patients in the regional hospital of Metlaoui."
    Professional training

Études et formations
  • Education

    2013 - 2014: Master Degree TICV (Information Processing and complexity of living systems) at the National School of Engineers, Tunis (ENIT).

    2009 - 2013: Engineering Degree in the higher school of Statistics and Information Analysis of Tunis (ESSAIT).

     2007 - 2 009: Passing preparatory cycle for engineering studies at the Higher Institute of Applied Science and Technology of Gabes (ISSATG).

    2007: Baccalaureate Degree in Technology, secondary school of Metlaoui

    Skills

    Mathematics and Statistics
    : Data Analysis, Time series
    , forecasting techniques, functional
    estimation, scoring, Operational Research, Neural networks, simul
    ation, Bayesian statistics,
    econometrics, data mining...

    Economics and Social Sciences:
    Macroeconomics, Microeconomics, national accounts, monetary
    economics, financial engineering, management and business rights, international economics,
    Economic Growth
    , Marketing,

    Clinical Research:
    Epidemiology, Life sciences Clinical trials (phase I
    -
    phase IV),
    Familiar
    with
    drug development life cycle and strong proficiency with the manipulation, analysis and reporting of
    clinical trials’ data
    , statistical programming and drafting of statistical reports, participation in the
    drafting of clinical study report (CSR), ICH, GCP, review of internal standard operational procedures
    (SOP)
    J
    uggling mutliple studies/projects simultaneously.
    ...
    Comput
    ing Tools

    Statistical programming: SAS, R, SPSS
    , Stata
    ,
    Python

    Microsoft Office (Word, Excel, Powerpoint), Latex.

    Knowledge in
    Design, object
    -
    oriented programming and
    web programming

    Multidimensional Data Base: SQL / MySQL, Oracle, PL / SQL...
    LANGUAGES
    English:
    Good (in listening, reading, speaking, and writing, TOEIC certificated)
    French:
    Fluent (in listening, reading, speaking, and writing)
    Arabic:
    Native speaker
    Activities:
    Member of the ATCC: Tunisian Association against Cancer

Autres compétences
Education

2013 - 2014: Master Degree TICV (Information Processing and complexity of living systems) at the National School of Engineers, Tunis (ENIT).

2009 - 2013: Engineering Degree in the higher school of Statistics and Information Analysis of Tunis (ESSAIT).

 2007 - 2 009: Passing preparatory cycle for engineering studies at the Higher Institute of Applied Science and Technology of Gabes (ISSATG).

2007: Baccalaureate Degree in Technology, secondary school of Metlaoui

Skills

Mathematics and Statistics
: Data Analysis, Time series
, forecasting techniques, functional
estimation, scoring, Operational Research, Neural networks, simul
ation, Bayesian statistics,
econometrics, data mining...

Economics and Social Sciences:
Macroeconomics, Microeconomics, national accounts, monetary
economics, financial engineering, management and business rights, international economics,
Economic Growth
, Marketing,

Clinical Research:
Epidemiology, Life sciences Clinical trials (phase I
-
phase IV),
Familiar
with
drug development life cycle and strong proficiency with the manipulation, analysis and reporting of
clinical trials’ data
, statistical programming and drafting of statistical reports, participation in the
drafting of clinical study report (CSR), ICH, GCP, review of internal standard operational procedures
(SOP)
J
uggling mutliple studies/projects simultaneously.
...
Comput
ing Tools

Statistical programming: SAS, R, SPSS
, Stata
,
Python

Microsoft Office (Word, Excel, Powerpoint), Latex.

Knowledge in
Design, object
-
oriented programming and
web programming

Multidimensional Data Base: SQL / MySQL, Oracle, PL / SQL...
LANGUAGES
English:
Good (in listening, reading, speaking, and writing, TOEIC certificated)
French:
Fluent (in listening, reading, speaking, and writing)
Arabic:
Native speaker
Activities:
Member of the ATCC: Tunisian Association against Cancer

D'autres freelances
Data Analyst SAS

Ces profils pourraient vous intéresser !
CV Data Scientist
Yining

Data Scientist

  • TOULOUSE
R PYTHON DATA EXCEL Microsoft Power BI SQL SAS JAVA
Disponible
CV Business Analyst/ Data Analyst
Babette

Business Analyst/ Data Analyst

  • YERRES
SQL SAS EXCEL JIRA AGILE DATA BIG DATA BI PYTHON Microsoft Power BI
Disponible
CV Data Scientist
Emilie

Data Scientist

  • SAINT-SAUVEUR-LE-VICOMTE
DATA R Microsoft Power BI EXCEL BIG DATA PYTHON SQL SAS Alteryx SAP
Bientôt disponible
CV Business Analyst BI
Yann

Business Analyst BI

  • ASNIÈRES-SUR-SEINE
Microsoft Power BI SQL SQL SERVER PYTHON DATA AGILE JIRA SAS
Disponible
CV Data Engineer
Koua Wilfried

Data Engineer

  • BOIS-COLOMBES
SQL PYTHON SAS Microsoft Power BI Google Cloud Platform LINUX
Disponible
CV Cloud Data Analyst | Python, Visualization, Stats & ML Enthusiast
Ludovic

Cloud Data Analyst | Python, Visualization, Stats & ML Enthusiast

  • VALENCE
PYTHON EXCEL SQL DATA Microsoft Power BI TABLEAU SOFTWARE BI R SAS SSAS
Disponible
CV Senior Data Analyst
Aboubakar

Senior Data Analyst

  • CRÉTEIL
Dataiku SAS SQL DATA TABLEAU SOFTWARE BIGQUERY PYTHON Microsoft Power BI Google Cloud Platform
Disponible
CV Actuaire IA, Data Scientist Senior, Economiste
Gilles Kué

Actuaire IA, Data Scientist Senior, Economiste

  • CHAMBOURCY
DATA R SAS PYTHON Lean Six Sigma SQL AGILE Microsoft Power BI BIG DATA EXCEL
CV Data Scientist/analyst
Mouad

Data Scientist/analyst

  • CHÂTILLON
Dataiku PYTHON SQL Microsoft Power BI AZURE Snowflake SQL SERVER SAS
CV Data Analyst / Data Scientist / Développeur Full Stack
Ariel

Data Analyst / Data Scientist / Développeur Full Stack

  • CRÉTEIL
SQL PYTHON R AZURE Microsoft Power BI SAS MONGODB DJANGO JAVASCRIPT